Create Alert
Watchlist

Cohance Lifesciences

₹559.45
-10.35 (1.82%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
569.80
Prev. Close
569.80
Volume
3,06,353
Total traded value
17.14 Cr
Upper Circuit
683.75
Lower Circuit
455.85

Fundamentals

Market Cap₹21,839Cr
ROE8.61%
P/E Ratio(TTM)69.70
EPS(TTM)8.19
P/B Ratio5.77
Dividend Yield0.00%
Industry P/E33.01
Book Value99.01
Debt to Equity0.12
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Cohance Lifesciences

Suven Pharma is an integrated Contract Development and Manufacturing Operations (CDMO) company, serving leading global pharmaceutical and fine chemical majors in their new product development initiatives. The company's primary ambition is to grow and establish itself as India's most admired CDMO company by the year 2029. Its business focuses on providing services ranging from Custom Synthesis and Process R&D to large-scale contract manufacturing of intermediates, APIs, and final drug formulations. The firm offers a complete range of services covering all activities from initial process research and development to late-stage clinical trials and commercial manufacturing. Suven works with some of the world's top innovator companies, having served more than 30 customers over the last five years. This commitment to reliable, on-time delivery has enabled it to emerge as a leading global player in the CDMO industry.;
Parent OrganisationCohance Lifesciences
Managing DirectorDr V. Prasada Raju
NSE SymbolCOHANCE

Shareholding Pattern

Dec '24
Mar '25
May '25
Jun '25
Sep '25
Promoters
57.49%
Mutual Funds
16.49%
Retail And Others
15.18%
Foreign Institutions
6.51%
Other Domestic Institutions
4.33%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
38.20
Emcure Pharmaceuticals
NA
(0.00%)
31.53
Wockhardt
NA
(0.00%)
-410.25
Natco Pharma
NA
(0.00%)
9.82